These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36122348)

  • 21. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.
    Winer A; Adams S; Mignatti P
    Mol Cancer Ther; 2018 Jun; 17(6):1147-1155. PubMed ID: 29735645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The crude extract of Corni Fructus inhibits the migration and invasion of U-2 OS human osteosarcoma cells through the inhibition of matrix metalloproteinase-2/-9 by MAPK signaling.
    Liao CL; Lin JH; Lien JC; Hsu SC; Chueh FS; Yu CC; Wu PP; Huang YP; Lin JG; Chung JG
    Environ Toxicol; 2015 Jan; 30(1):53-63. PubMed ID: 23955962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
    Li W; Saji S; Sato F; Noda M; Toi M
    Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 Inhibitor.
    Senn N; Ott M; Lanz J; Riedl R
    J Med Chem; 2017 Dec; 60(23):9585-9598. PubMed ID: 28953404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments.
    Lin H; Xu P; Huang M
    Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery.
    Baidya SK; Banerjee S; Adhikari N; Jha T
    J Med Chem; 2022 Aug; 65(16):10709-10754. PubMed ID: 35969157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
    Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
    Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening.
    Gimeno A; Cuffaro D; Nuti E; Ojeda-Montes MJ; Beltrán-Debón R; Mulero M; Rossello A; Pujadas G; Garcia-Vallvé S
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of 4-phenoxybenzenesulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Mao J; Zhang H; Wang X; Gao J; Tang J; Zhang J
    Biosci Trends; 2020 Jul; 14(3):192-199. PubMed ID: 32389938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors.
    Kaplancikli ZA; Altıntop MD; Atli O; Sever B; Baysal M; Temel HE; Demirci F; Ozdemir A
    Anticancer Agents Med Chem; 2017; 17(5):674-681. PubMed ID: 27491937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
    Yang JS; Lin CW; Su SC; Yang SF
    Expert Opin Drug Metab Toxicol; 2016; 12(2):191-200. PubMed ID: 26852787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in the development of matrix metalloproteinase inhibitors.
    Tu G; Xu W; Huang H; Li S
    Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of matrix metalloproteinase inhibitors by chemical arrays.
    Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
    Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.
    Zhang C; Kim SK
    Mar Drugs; 2009 Mar; 7(2):71-84. PubMed ID: 19597572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactives from Marine Organisms and their Potential Role as Matrix Metalloproteinase Inhibitors.
    Thomas NV; Monica Diyya AS; Kim SK; Faraj KA; Ghafoor DD; Qian ZJ; Tigabu BM
    Curr Pharm Des; 2022; 28(41):3351-3362. PubMed ID: 36411577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs.
    Jain M; Harburn JJ; Gill JH; Loadman PM; Falconer RA; Mooney CA; Cobb SL; Berry DJ
    J Med Chem; 2017 May; 60(10):4496-4502. PubMed ID: 28471664
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Balsa LM; Quispe P; Baran EJ; Lavecchia MJ; León IE
    Metallomics; 2020 Dec; 12(12):1931-1940. PubMed ID: 33107537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
    Zhang H; Wang X; Mao J; Huang Y; Xu W; Duan Y; Zhang J
    Bioorg Med Chem; 2018 Aug; 26(15):4363-4374. PubMed ID: 30093347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomolecular basis of matrix metallo proteinase-9 activity.
    Swetha R; Gayen C; Kumar D; Singh TD; Modi G; Singh SK
    Future Med Chem; 2018 May; 10(9):1093-1112. PubMed ID: 29676173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.